미국 · 보도자료 · NeurAxis, Inc. · 2026-09-29 11:00
상업적 성장 가속화 위해 크레이그 블랜차드 최고상업책임자(CCO) 선임
CARMEL, Ind., Sept. 29, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced the appointment of Craig Blanchard as Chief Commercial Officer. In this role, Mr. Blanchard will oversee the Company’s commercial fu
